NOVEL TREATMENT OF GEFITINIB-RESISTANT NON-SMALL-CELL LUNG CANCER
    1.
    发明申请
    NOVEL TREATMENT OF GEFITINIB-RESISTANT NON-SMALL-CELL LUNG CANCER 审中-公开
    耐药性非小细胞肺癌的新疗法

    公开(公告)号:US20140371254A1

    公开(公告)日:2014-12-18

    申请号:US14285651

    申请日:2014-05-23

    CPC classification number: A61K31/4741

    Abstract: The present invention discloses a method of preventing and treating Gefitinib-resistant non-small-cell lung cancer, comprising administering an effective amount of an alkaloid. A pharmaceutical composition comprising an alkaloid admixed with a pharmaceutical carrier for treating Gefitinib-resistant non-small-cell lung cancer is also disclosed therein.

    Abstract translation: 本发明公开了一种预防和治疗吉非替尼抗性非小细胞肺癌的方法,包括给予有效量的生物碱。 还公开了包含与用于治疗吉非替尼非小细胞肺癌的药物载体混合的生物碱的药物组合物。

Patent Agency Ranking